CLINICAL TRIALS PROFILE FOR OXYMETAZOLINE HYDROCHLORIDE; TETRACAINE HYDROCHLORIDE
✉ Email this page to a colleague
All Clinical Trials for oxymetazoline hydrochloride; tetracaine hydrochloride
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT01302483 ↗ | Safety and Effectiveness of Kovacaine Nasal Spray for Dental Anesthesia | Completed | Ground Zero Pharmaceuticals | Phase 2 | 2008-12-01 | The purpose of this study was to determine the safety and efficacy of Kovacaine Mist (3% tetracaine HCl with 0.05% oxymetazoline HCl) for anesthesia of the maxillary teeth for dental procedures. |
NCT01302483 ↗ | Safety and Effectiveness of Kovacaine Nasal Spray for Dental Anesthesia | Completed | Rho, Inc. | Phase 2 | 2008-12-01 | The purpose of this study was to determine the safety and efficacy of Kovacaine Mist (3% tetracaine HCl with 0.05% oxymetazoline HCl) for anesthesia of the maxillary teeth for dental procedures. |
NCT01302483 ↗ | Safety and Effectiveness of Kovacaine Nasal Spray for Dental Anesthesia | Completed | St. Renatus, LLC | Phase 2 | 2008-12-01 | The purpose of this study was to determine the safety and efficacy of Kovacaine Mist (3% tetracaine HCl with 0.05% oxymetazoline HCl) for anesthesia of the maxillary teeth for dental procedures. |
NCT01304316 ↗ | Dose-Escalation Safety and Pharmacokinetic Study of K305 | Completed | Ground Zero Pharmaceuticals | Phase 2 | 2010-09-01 | The purpose of this study is to determine the pharmacokinetics/pharmacodynamics and safety of a nasal spray containing the anesthetic drug tetracaine in combination with oxymetazoline |
NCT01304316 ↗ | Dose-Escalation Safety and Pharmacokinetic Study of K305 | Completed | Rho, Inc. | Phase 2 | 2010-09-01 | The purpose of this study is to determine the pharmacokinetics/pharmacodynamics and safety of a nasal spray containing the anesthetic drug tetracaine in combination with oxymetazoline |
NCT01304316 ↗ | Dose-Escalation Safety and Pharmacokinetic Study of K305 | Completed | St. Renatus, LLC | Phase 2 | 2010-09-01 | The purpose of this study is to determine the pharmacokinetics/pharmacodynamics and safety of a nasal spray containing the anesthetic drug tetracaine in combination with oxymetazoline |
NCT01479517 ↗ | Open-Label Study of Efficacy and Recommended Dose of Kovacaine Mist for Anesthetizing Maxillary Teeth | Completed | Rho, Inc. | Phase 2 | 2012-01-01 | The purpose of this study is to evaluate the efficacy of and recommended dosing regimen for unilateral administration of Kovacaine Mist in inducing pulpal anesthesia of the maxillary teeth for dental procedures. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for oxymetazoline hydrochloride; tetracaine hydrochloride
Condition Name
Condition MeSH
Condition MeSH for oxymetazoline hydrochloride; tetracaine hydrochloride | |
Intervention | Trials |
Dental Pulp Diseases | 2 |
Stomatognathic Diseases | 1 |
Drug-Related Side Effects and Adverse Reactions | 1 |
Pulpitis | 1 |
[disabled in preview] | 0 |
This preview shows a limited data set Subscribe for full access, or try a Trial |
Clinical Trial Locations for oxymetazoline hydrochloride; tetracaine hydrochloride
Trials by Country
Clinical Trial Progress for oxymetazoline hydrochloride; tetracaine hydrochloride
Clinical Trial Phase
Clinical Trial Sponsors for oxymetazoline hydrochloride; tetracaine hydrochloride
Sponsor Name